Latest News on iShares Russell Top 200 Index (IWL) ETF

  • Eli Lilly‚Äôs 1Q17 Earnings: Strattera and Other Neuroscience Products [May 1 2017 07:38 AM]
  • Strattera, a drug for attention-deficit hyperactivity disorder, reported a 4% increase in revenues to $196.2 million in 1Q17, compared to $188.1 million in 1Q16. Read more about this iShares Russell Top 200 Index (IWL) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center